Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1977 Jan;15(1):115–123. doi: 10.1128/iai.15.1.115-123.1977

Effects of tobacco smoke on chemotaxis and glucose metabolism of polymorphonuclear leukocytes.

R B Bridges, J H Kraal, L J Huang, B M Chancellor
PMCID: PMC421336  PMID: 832896

Abstract

The effect of tobacco smoke on in vitro chemotaxis of human polymorphonuclear leukocytes (PMN) was determined. Whole tobacco smoke, gas phase of smoke, and water-soluble fraction were potent inhibitors of PMN chemotaxis. The results indicated that PMN chemotaxis was inhibited in a dose-dependent manner by water-soluble fraction and that this suppression was not a result of cytotoxicity. In an attempt to determine the mechanism of chemotaxis inhibition, the effect of tobacco smoke on glucose metabolism of PMN was studied. Exposure of PMN to whole smoke, gas phase, or water-soluble fraction resulted in an increase (twofold) in glucose catabolism via both glycolysis and the hexose monophosphate shunt, with no apparent effects on the metabolism of glucose via the tricarboxylic acid cycle. These results suggest that the inhibitory effects of tobacco smoke on PMN chemotaxis were not directly attributable to effects on glucose metabolism of these cells. Further, the inhibitory effects of water-soluble fraction on PMN chemotaxis were shown to be largely irreversible and preventable in the presence of cysteine. Thus, the major inhibitory effects of tobacco smoke probably result from the direct action of oxidants and/or thiol-reactive substances on PMN.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. W., Stowring L. Glycolytic and gluconeogenic enzyme activities in renal cortex of diabetic rats. Am J Physiol. 1973 Apr;224(4):930–936. doi: 10.1152/ajplegacy.1973.224.4.930. [DOI] [PubMed] [Google Scholar]
  2. Anderson R., Rabson A. R., Sher R., Koornhof H. J. Letter: The N.B.T. test in cigarette smokers. Am J Clin Pathol. 1974 Jun;61(6):879–879. doi: 10.1093/ajcp/61.6.879. [DOI] [PubMed] [Google Scholar]
  3. BOYDEN S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 Mar 1;115:453–466. doi: 10.1084/jem.115.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boxer L. A., Hedley-Whyte E. T., Stossel T. P. Neutrophil action dysfunction and abnormal neutrophil behavior. N Engl J Med. 1974 Nov 21;291(21):1093–1099. doi: 10.1056/NEJM197411212912101. [DOI] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. COHN Z. A., MORSE S. I. Functional and metabolic properties of polymorphonuclear leucocytes. I. Observations on the requirements and consequences of particle ingestion. J Exp Med. 1960 May 1;111:667–687. doi: 10.1084/jem.111.5.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carruthers B. M. Leukocyte motility. I. Method of study, normal variation, effect of physical alterations in environment, and effect of iodoacetate. Can J Physiol Pharmacol. 1966 May;44(3):475–485. doi: 10.1139/y66-056. [DOI] [PubMed] [Google Scholar]
  8. Clark R. A., Kimball H. R. Defective granulocyte chemotaxis in the Chediak-Higashi syndrome. J Clin Invest. 1971 Dec;50(12):2645–2652. doi: 10.1172/JCI106765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eichel B., Shahrik H. A. Tobacco smoke toxicity: loss of human oral leukocyte function and fluid-cell metabolism. Science. 1969 Dec 12;166(3911):1424–1428. doi: 10.1126/science.166.3911.1424. [DOI] [PubMed] [Google Scholar]
  10. Goetzl E. J., Austen K. F. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization. J Exp Med. 1972 Dec 1;136(6):1564–1580. doi: 10.1084/jem.136.6.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goetzl E. J., Austen K. F. Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. J Clin Invest. 1974 Feb;53(2):591–599. doi: 10.1172/JCI107594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Green G. M. Cigarette smoke: protection of alveolar macrophages by glutathione and cysteine. Science. 1968 Nov 15;162(3855):810–811. doi: 10.1126/science.162.3855.810. [DOI] [PubMed] [Google Scholar]
  13. Harris J. O., Swenson E. W., Johnson J. E., 3rd Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Invest. 1970 Nov;49(11):2086–2096. doi: 10.1172/JCI106426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KARNOVSKY M. L. Metabolic basis of phagocytic activity. Physiol Rev. 1962 Jan;42:143–168. doi: 10.1152/physrev.1962.42.1.143. [DOI] [PubMed] [Google Scholar]
  15. Keller H. U., Borel J. F., Wilkinson P. C., Hess M. W., Cottier H. Re-assessment of Boyden's technique for measuring chemotaxis. J Immunol Methods. 1972 Jan;1(2):165–168. doi: 10.1016/0022-1759(72)90043-9. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Miller M. E., Oski F. A., Harris M. B. Lazy-leucocyte syndrome. A new disorder of neutrophil function. Lancet. 1971 Apr 3;1(7701):665–669. doi: 10.1016/s0140-6736(71)92679-1. [DOI] [PubMed] [Google Scholar]
  18. Noble R. C., Penny B. B. Comparison of leukocyte count and function in smoking and nonsmoking young men. Infect Immun. 1975 Sep;12(3):550–555. doi: 10.1128/iai.12.3.550-555.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. OREN R., FARNHAM A. E., SAITO K., MILOFSKY E., KARNOVSKY M. L. Metabolic patterns in three types of phagocytizing cells. J Cell Biol. 1963 Jun;17:487–501. doi: 10.1083/jcb.17.3.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Park B. H., Holmes B. M., Rodey G. E., Good R. A. Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants. Lancet. 1969 Jan 18;1(7586):157–157. doi: 10.1016/s0140-6736(69)91172-6. [DOI] [PubMed] [Google Scholar]
  21. TENNANT J. R. EVALUATION OF THE TRYPAN BLUE TECHNIQUE FOR DETERMINATION OF CELL VIABILITY. Transplantation. 1964 Nov;2:685–694. doi: 10.1097/00007890-196411000-00001. [DOI] [PubMed] [Google Scholar]
  22. Ward P. A., Becker E. L. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase. J Exp Med. 1968 Apr 1;127(4):693–709. doi: 10.1084/jem.127.4.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ward P. A. Insubstantial leukotaxis. J Lab Clin Med. 1972 Jun;79(6):873–877. [PubMed] [Google Scholar]
  24. Warr G. A., Martin R. R. Chemotactic responsiveness of human alveolar macrophages: effects of cigarette smoking. Infect Immun. 1974 Apr;9(4):769–771. doi: 10.1128/iai.9.4.769-771.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES